• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

Viral myocarditis has been identified as a major cause of dilated cardiomyopathy (DCM) that
can lead to heart failure. Historically, Coxsackieviruses and adenoviruses have been …

RASopathies are a family of developmental disorders that share germline mutations in the
components of the RAS-MAPK pathway leading to dysregulated signalling. A high …

Dilated cardiomyopathy (DCM) is defined as dilation and/or reduced function of one or both
ventricles and remains a common disease worldwide. An estimated 40% of cases of familial …

The heart is imbued with a vast lymphatic network that is responsible for fluid homeostasis
and immune cell trafficking. Disturbances in the forces that regulate microvascular fluid …

Deep learning-based methods for cardiac MR segmentation have achieved state-of-the-art
results. However, these methods can generate incorrect segmentation results which can …

MicroRNAs (miRNAs) are a class of non-coding RNAs of about 20 nucleotides in length,
involved in the regulation of many biochemical pathways in the human body. The level of …

Dilated cardiomyopathy (DCM) is a heart muscle disease characterized by ventricular
dilation and systolic dysfunction in the absence of abnormal loading conditions or coronary …

Purpose Dilated cardiomyopathy (DCM) is a common form of cardiomyopathy and it is
associated with poor outcomes. A poor prognosis of DCM patients with low ejection fraction …